-transparent.png){kind=logo}
A recombinant IgG3 antibody with Phe-243 replaced by Ala (FA243) was expressed in a CHO-K1 parental cell line. The resulting IgG-Fc-linked carbohydrate was significantly alpha2,3-sialylated (53% of glycans), as indicated by normal- and reverse-phase HPLC analyses. Following transfection of a rat alpha2,6-sialyltransferase gene into this parental cell line, IgG-Fc-linked glycans were sialylated (60% of glycans) such that the ratio of alpha2,6- to alpha2,3-linked sialic acid was 0.9:1.0. By comparison, the wild-type IgG3 (F243) is minimally sialylated (2-3% alpha2,3-linked), thus suggesting that sialylation is controlled primarily by the protein structure local to the carbohydrate and that the two sialyltransferases compete to sialylate the nascent oligosaccharide. The additional alpha2,6-sialylation affected the function of the recombinant antibody. FA243 IgG3 having both alpha2,6 and alpha2,3-sialylation restored recognition to wild-type IgG3 levels for human FcgammaRI, FcgammaRII, and target cell lysis by complement. We discuss how sialylation linkage could modulate IgG function.
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
November 2007,
The Journal of biological chemistry,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
January 1999,
Cytotechnology,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
October 2009,
Biochemistry,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
November 2015,
The Journal of clinical investigation,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
January 2019,
mAbs,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
August 2023,
Cells,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
May 1993,
The Journal of rheumatology,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
August 2008,
Molecular cancer research : MCR,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
March 2005,
The Journal of biological chemistry,
R Jassal, and
N Jenkins, and
J Charlwood, and
P Camilleri, and
R Jefferis, and
J Lund
January 2001,
Glycoconjugate journal,
